TFFP (TFF Pharmaceuticals) Earnings per share growth rate in current year
TFF Pharmaceuticals (TFFP) has fully utilized its thin-film powder production capacities, yet liquidity shortages and delisting risks pose serious threats. The comparable year-over-year earnings per share growth rate shows a metric value of 0.00, which helps assess the model's sustainability. Business development relies on innovation licensing and the joint development of inhalable vaccines with pharmaceutical behemoths.
Financial and market metric breakdowns for TFF Pharmaceuticals (TFFP)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Aggregate Debt to Equity TFF Pharmaceuticals|TFFP - Long-Term Debt to Capital|Current Liabilities to Equity tffpharma.com|TFFP - Company Total Debt|Debt to Net Assets Ratio TFF Pharmaceuticals, Inc|TFFP - Company Long-Term Debt|Current Liabilities TFF Pharmaceuticals|Intermediate Coverage Ratio tffpharma.com
- net income and valuation multiples indicators:
TFFP - Net Profit|Projected Future Earnings TFF Pharmaceuticals|TFFP - Price to Earnings Ratio|Future Price to Earnings Multiple TFF Pharmaceuticals, Inc|TFFP - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio TFF Pharmaceuticals, Inc|TFFP - Operating profit EBITDA|Net earnings per share (EPS TTM) TFF Pharmaceuticals|TFFP - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months tffpharma.com|TFFP - Earnings growth in current year|Expected net earnings per share growth next year TFF Pharmaceuticals
- company sales and revenue statistics:
Summary company analysis:TFF Pharmaceuticals Inc. (TFFP)
The monetization dynamics of TFF Pharmaceuticals (TFFP) are directly reflected in the changes to net earnings per share. By analyzing the annual growth rate of earnings per share, investors can observe the daily revaluation of the efficiency of implementing drug-to-powder sublimation technology. The positive trend confirms market recognition of the elimination of the cold chain, although sharp spikes in this indicator may signal rising speculative risks.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Amneal - Net earnings per share growth this year|Net earnings per one share growth for the current year PRGO (Perrigo Company PLC)|Alvotech Corp - Earnings growth in current year|Earnings per share trend in current year LQDA|GLPG: Earnings growth in current year|Earnings per share trend in current year ANIP (anipharmaceuticals.com)|Net earnings per share growth this year MNKD|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira (PCRX)|SPRY: Earnings per share trend in current year|Earnings growth in current year TBPH (Theravance Biopharma)|Earnings per share increase in current year AQST|scPharma - Earnings growth in current year|TECX - Earnings growth in current year|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|China SXT Pharmaceuticals, Inc. - Earnings per share increase in current year|Earnings per share growth in current year Eupraxia Pharmaceuticals, Inc.|Net earnings per share growth this year bioharvest.com (BHST)|Earnings growth in current year EXOZ|Earnings growth in current year oramed.com (ORMP)|Earnings growth in current year ENTX (Entera Bio)|HYFT - Net earnings per share growth this year|ABVC BioPharma - Earnings growth in current year|Earnings per share growth rate in current year cumberlandpharma.com|QNTM (Quantum BioPharma) - Net earnings per share growth this year|FibroGen Inc (FGEN) - Earnings growth in current year|Net earnings per share growth this year TELO|RANI (Rani Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year SNYR|Expected net earnings per share growth this year rallybio.com|Earnings growth in current year LEXX (Lexaria Bioscience Corp.)|PULM - Net earnings per share growth this year|Pheton - Earnings growth in current year|APM - Earnings growth in current year|Lyra Therapeutics, Inc. (LYRA) - Earnings per share growth in current year|IBO (Impact BioMedical, Inc.) - Earnings per share growth in current year|Earnings per share growth in current year TNF Pharmaceuticals Inc.|cbdMD Corp (YCBD) - Expected net earnings per share growth this year|Net earnings per share growth this year PRFX (PainReform Limited)|Net earnings per one share growth for the current year CYTO|Earnings growth in current year LIPO (Lipella Pharmaceuticals)|OPTN (optinose.com) - Earnings per share trend in current year|Pieris Pharmaceuticals, Inc. - Earnings growth in current year|Earnings per share trend in current year PROC|Petros (PTPI) - Earnings per share growth in current year|Earnings per share trend in current year QLI (Qilian International Corp)|Earnings per share growth in current year Acelyrin, Inc.
